Nevirapine
- TRADE NAME: Viramune (Boehringer Ingelheim)
- INDICATIONS: HIV infection
- CLASS: Antiretroviral, CYP3A4 inducer, Non-nucleoside reverse transcriptase inhibitor
- HALF-LIFE: 45 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amiodarone, Amprenavir, Atazanavir, Carbamazepine, Caspofungin, Clarithromycin, Clonazepam, Cyclosporine, Diltiazem, Disopyramide, Doravirine, Efavirenz, Ethosuximide, Etravirine, Fentanyl, Fluconazole, Fosamprenavir, Indinavir, Itraconazole, Ketoconazole, Levonorgestrel, Lidocaine, Lopinavir, Midazolam, Nifedipine, Rifampin, Rilpivirine, Simeprevir, St John's Wort, Verapamil
PREGNANCY CATEGORY: B
LIFE-THREATENING (INCLUDING FATAL) HEPATOTOXICITY and SKIN REACTIONS
See full prescribing information for complete boxed warning
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric